Chembio Stock Story

CEMI
 Stock
  

USD 1.04  0.06  5.45%   

Chembio investor sentiment overview provides quick insight into current market opportunities from investing in Chembio Diagnostics. The current market sentiment together Chembio Diagnostics' historical and current headlines can help investors to time the market. Many technical investors use Chembio Diagnostics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Chembio Diagnostics Hype Analysis, Chembio Diagnostics Correlation and Chembio Diagnostics Performance.
  
Chembio Diagnostics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Chembio daily returns and investor perception about the current pice of Chembio Diagnostics as well as its diversification or hedging effects on your existing portfolios.

Chembio Diagnostics Sentiment by News Outlets

benzinga news
news
news
news
Macroaxis News: globenewswire.com
businessinsider News

Chembio Diagnostics Twitter Pulse

Investors have realized that leveraging social media to get the fastest information affecting stock prices isn't a theory anymore, it is a reality, and Twitter offers a platform that can outpace even the most trustworthy news aggregators. The influence of social media outlets on stock markets and stock prices of entities such as Chembio Diagnostics has been proven in recent years. We extract public sentiment from Twitter posts that could be utilized to determine whether Chembio Diagnostics' prices will increase or decrease.
Twitter's metrics such as likes, followers, and engagement can be good indicators of the reliance and probability of reaction to a specific tweet regarding Chembio Diagnostics. Our Twitter sentiment analysis of Chembio Stock helps investors make informed decisions by leveraging the power of the community. It is a perfect supplementary tool for any beginner or an experienced trader.
Rapid Test Kits Market 2022 Study An Emerging Hint of Opportunity Cellex, Abbott, Roche Indian Defence News - Indian Defence News
Rapid Test Kits Market 2022 Study An Emerging Hint of Opportunity Cellex, Abbott, Roche Indian Defence News Indian Defence News

news
  
Rapid Test Kits Market 2022 Study An Emerging Hint of Opportunity Cellex, Abbott, Roche Indian Defence News Indian Defence News

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Chembio Diagnostics Fundamental Analysis

We analyze Chembio Diagnostics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chembio Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chembio Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned by Insiders

Shares Owned by Insiders Comparative Analysis

Chembio Diagnostics is currently under evaluation in shares owned by insiders category among related companies. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Chembio Diagnostics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chembio Diagnostics stock to make a market-neutral strategy. Peer analysis of Chembio Diagnostics could also be used in its relative valuation, which is a method of valuing Chembio Diagnostics by comparing valuation metrics with similar companies.

Peers

Chembio Diagnostics Related Equities

HDHome Depot   0.74   
0%
38.0%
BABoeing Company   0.53   
0%
27.0%
IBMInternational Business Machines   0.11   
0%
5.0%
CSCOCisco Systems   0.02   
0%
1.0%
INTCIntel Corp   0.03   
1.0%
0%
JNJJohnson Johnson   0.49   
25.0%
0%
AAgilent Technologies   0.87   
45.0%
0%
SBUXStarbucks Corp   1.32   
69.0%
0%
BACBank Of America   1.41   
74.0%
0%
TATT Inc   1.91   
100.0%
0%
Continue to Chembio Diagnostics Hype Analysis, Chembio Diagnostics Correlation and Chembio Diagnostics Performance. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
33.2 M
Quarterly Revenue Growth YOY
1.16
Return On Assets
-0.26
Return On Equity
-1.53
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.